title: Cancer gene therapy: Part 2. Candidate transgenes and their clinical development.
authors.affiliation: CRC Centre for Cell and Molecular Biology, Institute for Cancer Research, London, UK. kevinh@icr.ac.uk
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Harrington
authors.forename: Alan A
authors.initials: AA
authors.lastname: Melcher
authors.forename: Andrew R
authors.initials: AR
authors.lastname: Bateman
authors.forename: Atique
authors.initials: A
authors.lastname: Ahmed
authors.forename: Richard G
authors.initials: RG
authors.lastname: Vile
mesh_terms: D019496:Cancer Vaccines / Q000235:genetics / Q000627:therapeutic use; D016207:Cytokines / Q000235:genetics; D004798:Enzymes / Q000235:genetics; D016147:Genes, Tumor Suppressor; D015316:Genetic Therapy; D006801:Humans; D008285:Major Histocompatibility Complex / Q000235:genetics; D009369:Neoplasms / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000627:therapeutic use; D011355:Prodrugs / Q000627:therapeutic use; D019076:Transgenes
chemical_list: D019496:Cancer Vaccines; D016207:Cytokines; D004798:Enzymes; D016376:Oligonucleotides, Antisense; D011355:Prodrugs